Prevent Cardiac Surgery Associated AKI Trial
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 242 participants.
Also called NCT06620523
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 242 participants
- Sponsor
- Registry
-
NCT06620523
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06620523. Randomized; triple masking; primary purpose treatment. Start 2024-07-18 (actual); primary completion 2027-06-17 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prevent Cardiac Surgery Associated AKI Trial
- Condition
- Renal Failure
- Condition
- Coronary Artery Disease
- Condition
- Surgery
- Condition
- Surgery-Complications
- Intervention (Drug)
- CoQ10 1200 mg orally with Glutathione 1000 mg orally
- Intervention (Drug)
- Group B: Placebo CoQ10 orally and Placebo Glutathione orally
- Lead sponsor
- George Washington University
Record details
- Record id
cardio:ct-nct06620523- Content hash
f54624f96bcf8922b895509d2a4d18e89028684c493788a10464f9983c4a4a12